- Global Pharma News & Resources
24-Mar-2021 - 25-Mar-2021

Online Course: Strategic Account Management in Pharma by David Wright & Pijush Bose

Learn how to uncover the unmet needs of strategic accounts and to develop patient-centric strategies that drive value for both your company, your account and patients – Know how to design and organise well-coordinated multi-functional account teams that result in much more effective KAM – Learn how to set up a KAM plan and to measure KAM success.

Why You Should Attend

KAM in the pharma industry is complex and it is no secret that pharma companies have found it difficult to maintain sustainable success with KAM programmes in increasingly complex healthcare systems with progressively more demanding customers.

The Content: This course is rich in insights and handy tools, alongside first-hand experience and real examples, all of which will equip you to dramatically improve your capability to manage and grow high value strategic accounts. It also deals with the complexities in moving to a multi-functional approach, encompassing Market Access, Medical Science Liaison, Sales….

The Experts: David and Pijush are a perfect complement of each other. David’s expertise is based on both academic KAM research (incl. significant KAM industry research in pharma) and consulting work for some of the world’s top pharma organisations on multi-country KAM programmes. He has over 20 years’ experience in leading KAM programmes across multiple complex and highly regulated sectors that include Pharma, Aerospace, IT, Utilities and Automotive. David has both chaired and presented at international KAM conferences. Pijush brings a lot of real-life pharma company experience to the course: prior to consultancy, he gained 18+ years of experience in Field Force Effectiveness, Strategic Account Management, CRM and Business Analytics at Abbott/AbbVie, leading regional and global initiatives.

Strategic Account Management in Pharma is the only available public training course delivered by David Wright and Pijush Bose on this topic.